Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis

Devreese, Katrien M.J., de Groot, Philip G., de Laat, Bas, Erkan, Doruk, Favaloro, Emmanuel J., Mackie, Ian, Martinuzzo, Marta, Ortel, Thomas L. +5 more·2020·Journal of Thrombosis and Haemostasis
DOI 10.1111/jth.15047

Cited by (441)

Items 301–400 of 441

  1. Clinical Laboratories Need More Information About Commercially Available Reagents to Prepare for the IVDR : A Call From the ICSH
    Dominique Lasne, Sophie Testa, Steve Kitchen, Chris Gardiner, Piet Meijer, François Mullier · 2025 · International Journal of Laboratory Hematology
  2. Novel Clinical and Laboratory Correlations for Antiphospholipid Syndrome
    Amaya Llorente‐Chávez, Sebastián Burgos Canales, Ángel Miguel Beverido-Florido, Alfonso Orozco Collazo · 2025 · Clinics in Laboratory Medicine
  3. Clinical and serological markers of antiphospholipid syndrome in Saudi Arabia: A multicenter retrospective study
    Ahmad Alshomar · 2025 · International Journal of Health Sciences
  4. Unmasking the phospholipid-induced “hook effect” and its implications - increasing phospholipid can also lead to a longer clotting time in coagulation assays
    Liqin Ling, Chaonan Liu, Xunbei Huang, Shuang Wang, Zhengping Yu, Jing Zhou · 2025 · Journal of Thrombosis and Thrombolysis
  5. Laboratory thrombophilia screening: essentials for hematologists
    Paul Alexander Kyrle · 2021 · memo - Magazine of European Medical Oncology
  6. Issue Information
    2020 · Journal of Thrombosis and Haemostasis
  7. Letter to the editors-in-chief: Gender differences in the dilute Russell's viper venom time lupus anticoagulant test
    Svein Joar Auglænd Johnsen, Øyvind Skadberg, Kine N. Svendsen, Arne Åsberg · 2022 · Thrombosis Research
  8. Antiphospholipid antibodies exacerbate damage following oxygen deprivation-reperfusion injury in an in vivo model for stroke and in ex vivo blood derived endothelial cells
    Charis Pericleous, Daniel J. Stuckey, Robert T. Maughan, Koralia E. Paschalaki, Lida Kabir, Lauren Bourke, Rohan Willis, Anisur Rahman, ANNA MARIA RANDI, Deepa J. Arachchillage et al. · 2024 · medRxiv
  9. Pathogenesis of antiphospholipid antibody syndrome
    Ibrahim Tohidi‐Esfahani, Hannah Cohen, Yiannis Ioannou, Ian Giles · 2024 · Elsevier eBooks
  10. Evaluation of Activated Carbon Treatment on Overcoming the Interference of Rivaroxaban on the Detection of Functional Lupus Anticoagulant
    Songsong Lu, Nurzat Huerman, Meng Li · 2022 · Acta Haematologica
  11. The features of patients with lupus anticoagulant result presenting as negative screen test and positive normalized ratio
    Ning Tang, Yueyun Xiang, Dengju Li · 2022 · Thrombosis Research
  12. TROMBOSE VENOSA PROFUNDA COM EVOLUÇÃO PARA EMBOLIA PULMONAR: UMA REVISÃO DE LITERATURA
    JULIA SILVA SARKIS, MAIARA MALLMANN DE FREITAS, Bruna Gidiel Paim et al. · 2022 · Editora Pasteur eBooks
  13. Using weighted harmonic mean for prediction of APTT in the mixing test
    Mitsuhiro Uchiba, Masao Matsuoka · 2022 · Thrombosis Update
  14. Bilans d’hémostase sous anticoagulants oraux directs
    Carole Émile · 2022 · Option/Bio
  15. Complications thrombotiques graves du syndrome des antiphospholipides et d’un lupus érythémateux disséminé non diagnostiqué
    Megan R.W. Barber, Ann Elaine Clarke, Corey D. Adams · 2023 · Canadian Medical Association Journal
  16. Evaluation of newly developed dilute Russell's viper venom reagents for lupus anticoagulant detection
    Laurie Talon, Virginie Fourneyron, Maryse Tardieu · 2023 · International Journal of Laboratory Hematology
  17. Trombofilia in pazienti con pregressa trombosi e consanguinei sani: dallo studio di popolazione alla medicina personalizzata
    Gianluca Gessoni, Sara Valverde, Marco MONTANARI · 2023 · La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine
  18. Quantitative Risk for Single-Positive Lupus Anticoagulant Results With Different Anticoagulants
    Waleed Khan, Christopher A. Tormey, Henry M. Rinder, Alexa J. Siddon · 2023 · American Journal of Clinical Pathology
  19. Association between cumulative dose of hydroxychloroquine and electrocardiographic abnormalities in patients with systemic lupus erythematosus
    Jon Zubiaur Zamacola, Alba Herrero-Morant, Adrián Margarida de Castro · 2023 · European Journal of Internal Medicine
  20. The association of STAT4 single nucleotide polymorphisms with thrombotic manifestations in a cohort of patients with autoimmune diseases and antiphospholipid antibodies
    Magdalena Celińska‐Löwenhoff, Teresa Iwaniec, Sylwia Dziedzina, Marcin P. Kaczor, Maciej Pastuszczak, Jerzy Dropiński, Marek Sanak, Jacek Musiał · 2023 · Research Square
  21. Das Antiphospholipid-Syndrom
    Zsuzsanna Wolff · 2023 · Trillium Diagnostik
  22. Routine Lupus Anticoagulant Sensitive aPTT Testing Can Prevent Unnecessary LA Testing
    Bob Smit, Francisca Hudig, Jan‐Hendrik Venhuizen · 2023 · Clinical and Applied Thrombosis/Hemostasis
  23. Algorithmes décisionnels de l’allongement du temps de céphaline avec activateur (TCA)
    Claire Flaujac, Amélie Launois · 2023 · La Presse Médicale Formation
  24. Low Recurrent Thrombosis Rates in Single Positive Antiphospholipid Syndrome on Doac or Warfarin Therapy
    Brianna R. Bakow, Lisa R. Yanek, Mark Andrew Crowther · 2023 · SSRN Electronic Journal
  25. Association of anti-β2-glycoprotein I/HLA-DR complex antibody with arterial thrombosis in female patients with systemic rheumatic diseases
    Katsuhiko Yoneda, Yo Ueda, Kenji Tanimura · 2023 · Research Square
  26. Validation of mixing test-specific cut-off in lupus anticoagulant mixing test interpretation for multiple reagents
    Osamu Kumano, Gary W. Moore · 2023 · Thrombosis Research
  27. Nowe kryteria klasyfikacyjne zespołu antyfosfolipidowego — 2023
    Jacek Musiał · 2023 · Journal of Transfusion Medicine
  28. Pitfalls in antiphospholipid antibody testing: specifically interference from anticoagulation
    Hammad Ali, Connor R. Buechler, Oneeb Sanaullah, Paramarajan Piranavan · 2023 · Clinical Rheumatology
  29. Thrombotic Markers in Pregnant Patients with and without SARS-CoV-2 Infection
    Ann M. Bruno, Amanda A. Allshouse, Ashley E. Benson · 2023 · American Journal of Perinatology
  30. Interpreting coagulation mixing study results in the era of direct oral anticoagulants
    Moonjoo Kim, Eric Salazar, Bonnie Phillips, Lawrence Rice, Brian Castillo, Christopher M. Leveque, Jian Chen · 2023 · Blood Coagulation & Fibrinolysis
  31. A case of development of membranous nephropathy against the background of atypical hemolytic-uremic syndrome activated as a result of acute respiratory viral infection
    М. М. Батюшин, Белобородова Татьяна Петровна, Vyacheslav Leonidovich Korobka · 2023 · South Russian Journal of Therapeutic Practice
  32. Trombofilia a niedokrwienny udar mózgu
    Jacek Musiał · 2023 · Journal of Transfusion Medicine
  33. Thrombophilia and ischemic stroke
    Jacek Musiał · 2023 · Journal of Transfusion Medicine
  34. Lupus Erythematosus and Antiphospholipid Syndrome
    Jan Peter Dutz, Touraj Khosravi‐Hafshejani · 2024 · Wiley eBooks
  35. Factores asociados con el diagnóstico de síndrome antifosfolípido: ¿cuándo debemos solicitar los estudios?
    J. A. Sáenz, Óscar Múñoz, Paula Ruíz-Talero · 2024 · Revista Colombiana de Reumatología
  36. Antiphospholipides : de la biologie à la clinique en 2024
    Maxime Delrue, Valérie Eschwège · 2024 · Revue Francophone des Laboratoires
  37. Antiphospholipid-Syndrom: neue Klassifikationskriterien und Implikationen für die Praxis
    Ana‐Luisa Stefanski, Thomas Dörner · 2024 · Aktuelle Rheumatologie
  38. Antiphospholipid Syndrome and Stroke: Diagnosis and Management
    Prabal Mittal, Maria Efthymiou, Zara Sayar · 2024 · Springer eBooks
  39. Diferencias en la conclusión final de la búsqueda de anticoagulante lúpico en pacientes anticoagulados con antagonistas de la vitamina K.
    Ayelén Bertoncin, Cristina Duboscq, Florencia Bossio, J Lopez Romera, Jose Manuel Ceresetto, German R. Stemmelin · 2024 · Revista Hematología
  40. Antiphospholipid Antibody Testing in a Maximum Care Hospital: Method-Dependent Differences
    Marija Kocijančić, Thomas Goj, Andreas Peter, Reinhild Klein, Sebastian Hörber · 2024 · Journal of Clinical Medicine
  41. КЛІНІЧНИЙ ВИПАДОК УСПІШНОГО ЛІКУВАННЯ ЗАТРИМКИ РОСТУ ПЛОДА У ЖІНКИ З АНТИФОСФОЛІПІДНИМ СИНДРОМОМ І СУБХОРІАЛЬНОЮ ГЕМАТОМОЮ (ІСТОРІЯ ХВОРОБИ)
    Л. Б. Маркін, А. І. Попович, M.P. Lysyy, О. І. Попович · 2024 · Актуальні питання педіатрії акушерства та гінекології
  42. Antiphospholipid syndrome: Classification versus diagnosis
    Doruk Erkan · 2024 · Medicina Clínica
  43. Laboratory Profile of Lupus Anticoagulant Positive Cases and its Association with Clinical Presentation- Experience from a Tertiary Care Centre in Southern India
    Pranav Raghuram, Mithraa Devi Sekar, Lokeshwari Srinivasan, Prabhu Manivannan, Debdatta Basu, Rakhee Kar · 2024 · Indian Journal of Hematology and Blood Transfusion
  44. Thrombophilia screening in clinical pathology: Guidelines and controversies
    Maryam Ahmed Almuhaysh, Jawaher Sadun Alsadun, Munirah Mohammed Almulhim, Maryam Mousa Ahmed Almousa, Ali Moharag Hadadi, Ola Abdullah Aljaafari, Ali Hassan Alhussain, Waseem Ali Alquwayi, Yasser Abdrab Alameer Alkuwaiti, Ahmed Mohammed Almehainy · 2022 · International Journal of Health Sciences
  45. Laboratory Diagnosis of Lupus Anticoagulant and Antiphospholipid Antibodies
    Mohammad Barouqa, Lucia R. Wolgast, Morayma Reyes Gil · 2024 · Elsevier eBooks
  46. Antiphospholipid Antibody Syndrome
    Pier Luigi Meroni, Caterina Bodio, Claudia Grossi, María Orietta Borghi · 2024 · Wiley eBooks
  47. Cytokine status and hemostasis disorders in children with juvenile idiopathic arthritis
    M. V. Gomellya, Анна Валерьевна Миронова, T. S. Krupskaya · 2024 · Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук
  48. Lupus anticoagulant associated with low grade B-cell lymphoma and IgM paraproteinaemia with lupus cofactor phenomenon on DRVVT and SCT assays - a possible novel association
    Ting Hon Stanford Li, Pui-Lun Yip, Hui Yiu Chan · 2024 · Thrombosis Journal
  49. Sex-specific cut-off for dilute Russell’s viper venom time lupus anticoagulant test may be of value
    Ning Tang, Yuanmei Luo, Mangui Li · 2024 · Research and Practice in Thrombosis and Haemostasis
  50. Exploring the association between Preeclampsia and antiphospholipid antibodies. New insights on the clinical criteria of APS. A prospective study
    Beatriz E. Grand, Sebastián Udry, Andrea Laura Avigliano · 2024 · Research Square
  51. Utility of phospholipid-sensitive and insensitive APTT pairs together with dRVVT in the diagnosis of lupus anticoagulant
    Ricardo R Forastiero, Ayelén Bertoncin, Florencia Bossio, Jose Manuel Ceresetto, German R. Stemmelin, Leonardo Bello, Maibi Apaclia, Cristina Duboscq · 2025 · Revista Hemostasia y Trombosis
  52. Overview of the Coagulation Cascade and Thrombophilic Disorders
    Lorraine A. Cafuir, Ana G. Antun · 2025 · Springer eBooks
  53. Recherche d’une thrombophilie biologique : propositions de la Société de Thrombose et d’Hémostase (SFTH), ex GFHT
    Yves Gruel, Pierre‐Emmanuel Morange, Marion Alhenc-Gelas, Élodie Boissier, Isabelle Gouin‐Thibault, Emmanuel de Maistre, Emmanuelle de Raucourt, Céline Desconclois, Claire Flaujac, M.-F. Hurtaud et al. · 2025 · Revue de biologie médicale.
  54. Coagulation Profile of Convalescent Plasma Donors and Recipients
    Hanna H. Pitkänen, Tuukka Helin, Tamim Khawaja et al. · 2025 · Clinical and Applied Thrombosis/Hemostasis
  55. Antiphospholipid syndrome associated with sicca syndrome
    Avni Kryeziu, Shend Kryeziu, Fatlinda Berisha · 2025 · Polish Annals of Medicine
  56. Associated factors of antiphospholipid syndrome. When do we need antiphospholipid antibodies?
    Jaime Andrés Escobar Sáenz, Óscar Muñoz Velandia, Paula Ruiz Talero · 2025 · Revista Colombiana de Reumatología (English Edition)
  57. Correlation Study Between Lupus Anticoagulant and Antiphosphatidyl Serine/Prothrombin Complex Along with Their Clinical Significance
    Githa Rachel Oommen, Mamta Soni · 2025 · Apollo Medicine
  58. A Rare Case of Hereditary Factor XI Deficiency Accompanied by Lupus Anticoagulant in an Adult Patient with Monoclonal Gammopathy of Undetermined Significance
    Hengwei Liu · 2025 · Internal Medicine
  59. Lupus anticoagulant-hypoprothrombinemia syndrome presenting as bleeding diathesis – A study of two cases
    Paruvathavarthini Thambiraj, Narasimhapriyan Kannan, Rakhee Kar · 2025 · Journal of Laboratory Physicians
  60. Assessment of antiphospholipid antibodies using enzyme-linked immunosorbent assay and chemiluminescent method
    Tatiana Magomedalievna Reshetnyak, Mariya V. Cherkasova, Fariza A. Cheldieva · 2025 · Modern Rheumatology Journal
  61. Reference intervals for coagulation parameters in chinese adults stratified by sex and age
    Xinxing Lei, Shao-Rong Qiu, Bin Wang · 2025 · Scientific Reports
  62. The clot cases conference: a proposed model to enhance multidisciplinary thrombosis care
    Anna L. Parks, Stephen L. Jenkins, Sara R. Vazquez · 2025 · Journal of Thrombosis and Thrombolysis
  63. Evaluation of International Council for Standardization in Haematology Recommendations on Activated Partial Thromboplastin Time Mixing Tests Using an Automated Haemostasis Analyser
    Shapla Kamali, Minal Dave, Priyanka Raheja, Suthesh Sivapalaratnam, Sean Platton · 2025 · International Journal of Laboratory Hematology
  64. Exploration de la coagulation
    Manal Ibrahim‐Kosta, Marie‐Christine Alessi, Corinne Frère · 2025 · Encyclopédie médico-chirurgicale. Hématologie
  65. The potential role of dilute Russell’s viper venom time ratio in predicting the identification of triple-positive antiphospholipid antibody profile
    Jing Yuan Tan, Wan Hui Wong, Cecilia Cheng Lai Ngan et al. · 2025 · Journal of Thrombosis and Haemostasis
  66. Optimizing antiphospholipid antibody testing: a real-world analysis of appropriateness and resource utilization
    Silvia Grazietta Foddai, Maria Infantino, Mariangela Manfredi, Francesca Pavia, Maurizio Benucci, Francesca Li Gobbi, Massimo Radin, Irene Cecchi, Alice Barinotti, Savino Sciascia · 2025 · Immunologic Research
  67. Development and initial content validation of a new version of the damage index in thrombotic antiphospholipid syndrome (DIAPSV2)
    María Victoria Goycochea Robles, Gabriela Medina, Claudia Mendoza Pinto, Claudia Meléndez Mercado, Laura-Aline Martínez-Martínez, Pamela Medina San Millán, Silvia Guzmán Vázquez, Aurora Angélica Pérez Ruiz, Mary‐Carmen Amigo · 2025 · Lupus
  68. Pitfalls in Interpreting Antiphospholipid Antibodies in Rheumatic Diseases
    Eleftherios Pelechas, Panagiota Karagianni, Evripidis Kaltsonoudis · 2025 · Springer eBooks
  69. Improving Lupus Anticoagulant Detection in Heparinized Patients: An Automated Heparin-Resistant Recalcifying Solution
    Agathe Herb, Nathan Drouin, Amélie Rist · 2025 · Seminars in Thrombosis and Hemostasis
  70. High incidence of thrombin generation resistance to thrombomodulin in patients with unprovoked venous thromboembolism
    Jean‐Christophe Gris, Mathias Chéa, Eva Nouvellon, Raphaël De Jouvancourt, Mathieu Fortier, Chloé Bourguignon, Jeremy Laurent, Sylvie Bouvier, Antonia Pérez‐Martin · 2025 · Blood Vessels Thrombosis & Hemostasis
  71. Two-Stage Machine Learning Based Prediction of Thrombophilia Management
    Hannah L. McRae, Fabian Kahl, Maximilian Kapsecker, Heiko Rühl, Stephan Jonas, Bernd Pötzsch · 2025 · medRxiv
  72. Application of ACR/EULAR Classification Criteria in Real Life: Thrombotic Patients Positive for Lupus Anticoagulant Only
    Vittorio Pengo, Luca Sarti, Daniela Poli et al. · 2025 · Seminars in Thrombosis and Hemostasis
  73. Le syndrome des antiphospholipides en 2025
    Carole Émile · 2025 · Option/Bio
  74. Coming full circle: a prospective comparison of the South African and International Society on Thrombosis and Haemostasis protocols for dilute Russell’s viper venom testing
    Jenifer Vaughan, Katherine E. Hodkinson, Nomfundo Precious. Bhengu · 2025 · Journal of Medical Laboratory Science & Technology of South Africa
  75. Development of 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-A/B Report: Defining and Structuring the Clinical and Laboratory Domains
    Medha Barbhaiya, Stéphane Zuily, Mary‐Carmen Amigo, Tadej Avčin, María Laura Bertolaccini, David Ware Branch, Guilherme Ramires de Jesús, Katrien M.J. Devreese, Camille Francès, David González García et al. · 2025 · Current Rheumatology Reports
  76. Management and outcomes in patients with cryptogenic stroke and weakly positive antiphospholipid antibodies
    Macy L.E. Gatti, Steven Russell Messe, Adam C. Cuker · 2025 · Research and Practice in Thrombosis and Haemostasis
  77. New ACR/EULAR 2023 classification criteria for antiphospholipid syndrome, what should a gynaecologist know in 2025
    Anne Murarasu, G. Martin de Frémont, G. Guettrot-Imbert, Nathalie Morel, E. Pannier, Adriana Costin-Mihai, Nathalie Costedoat-Chalumeau, Véronique Le Guern · 2025 · Journal of Gynecology Obstetrics and Human Reproduction
  78. Clinical Significance of Weakly Positive Results in Initial Lupus Anticoagulant Testing
    Hyunwoo Kim, Ja Young Lee · 2025 · Imsang byeong'ri wa jeongdo gwanri/Journal of laboratory medicine and quality assurance
  79. Real-world Diagnosis and Testing of Acquired Hemophilia A in Japan: A Web-based Physician Survey
    Yoshinobu Seki, Madoka Go, Masahiro Ieko · 2026 · Internal Medicine
  80. Anti-beta2-glycoprotein I IgG antibodies are associated with early-onset cryptogenic ischemic stroke
    Nina Jaakonmäki, Tuukka Helin, Tímea Szántó et al. · 2026 · European Stroke Journal
  81. Catastrophic Antiphospholipid Syndrome
    Jean‐Christophe Gris, Mathias Chéa, Antonia Pérez‐Martin · 2026 · Seminars in Thrombosis and Hemostasis
  82. Catastrophic antiphospholipid syndrome: Clinical characteristics and outcomes in a non-caucasian population — A five-year experience from a single centre
    Rodolfo Jiménez-Soto, María Espinosa-León, José Emilio Said-Diego · 2026 · Lupus
  83. Anticoagulation Management of Patients with Antiphospholipid Syndrome Undergoing Cardiopulmonary Bypass in Cardiac Surgery: Challenges and Current Strategies
    Siqi Jiao, Shujie Yan, Yang Zhang, Yuan Teng, Gang Liu, Zhenzhen Li, Zhou Zhou, Bingyang Ji · 2026 · Seminars in Thrombosis and Hemostasis
  84. Normalization of activated partial thromboplastin time and diluted Russell’s viper venom time ratios can be safely omitted in the assessment of lupus anticoagulant
    Adrian Kimiaei, Jovan P. Antović, Charlotte Gran · 2026 · Research and Practice in Thrombosis and Haemostasis
  85. Can prothrombin time assays withstand the influence of antiprothrombin and anti-β2-glycoprotein I antibodies on the international normalized ratio?
    Arne Vandevelde, Katrien M.J. Devreese · 2026 · Research and Practice in Thrombosis and Haemostasis
  86. Coagulation parameter-based nomogram for the diagnosis of obstetric antiphospholipid syndrome and its subtypes
    Xuan Qi, Feifei Zhang, Xiaomeng Li · 2026 · Open Life Sciences
  87. Histopathological placental findings in antiphospholipid antibody carriers with a fetal loss beyond 12 weeks of pregnancy
    Sara Beça, Maria Borrell, Marta Santana-Domínguez · 2026 · Placenta
  88. Development of clinical manifestations in individuals positive for antiphospholipid antibodies according to the 2023 ACR/EULAR serological domains
    Rodrigo Cantera Estefanía, Rafael Gálvez Sánchez, Raquel García Ruiz et al. · 2026 · Seminars in Arthritis and Rheumatism
  89. Obstetric antiphospholipid syndrome: Advances in pathogenesis
    Shumin Wang, Huimin Liu, Wanrong Huang, Xun Zeng, Lang Qin, Rui Gao · 2026 · Autoimmunity Reviews
  90. Machine learning-based integration of antiphospholipid antibodies for predicting pregnancy outcomes in patients with recurrent spontaneous abortion: a multicenter prospective study
    Xinli Jiang, Jiatong Chai, Xingrong Li · 2026 · Clinical Chemistry and Laboratory Medicine (CCLM)
  91. Case Report: Differential diagnosis and clinical management of isolated prolonged activated partial thromboplastin time
    Lu Liu, Dongmei Guo · 2026 · Frontiers in Immunology
  92. A Diagnostic Journey through a Rare Hemostatic Disorder
    Zaraith Sanchez Oviol, Eric S Sorensen, Pablo Carmona · 2025 · The Journal of Applied Laboratory Medicine
  93. The role of clot waveform analysis and related parameters in the diagnosis and treatment of systemic lupus erythematosus
    Bin Yan, Haijun Guo, Yuanyuan Wen · 2026 · Thrombosis Research
  94. Management of patients with antiphospholipid antibodies or antiphospholipid syndrome during pregnancy
    Brooke S. Mills, Bonnie Lee Bermas · 2026 · Current Opinion in Rheumatology
  95. Exploration de la coagulation vue par le biologisteTests de coagulation de routine, bilan de thrombophilie et surveillance biologique des traitements anticoagulants
    F. Guillotin, S. Jaouen, Alexandra Yannoutsos · 2026 · EMC - Angéiologie
  96. Perspective Chapter: Testing for Lupus Anticoagulant – Is There Light at the End of the Tunnel?
    Kamal Fatmawati · 2026 · IntechOpen eBooks
  97. Updates in Antiphospholipid Syndrome Laboratory Diagnosis
    Geoffrey D. Wool · 2026 · Clinics in Laboratory Medicine
  98. Mathematical modeling of cross-mixing test dynamics in adult-onset lupus Anticoagulant–Associated hypoprothrombinemia syndrome
    Noriko Seno, Takafumi Ohama, Natsuko Morita · 2026 · Thrombosis Update
  99. Correlation between dilute Russell's viper venom time (dRVVT) and apixaban concentrations: Potential utility and limitations in emergency settings
    Totai Seeboonruang, Dollapak Apipongrat, Rattapan Lamool · 2026 · Thrombosis Research
  100. Current Indications for Thrombophilia Testing – A Modified Delphi Consensus Study in Switzerland
    Lukas Graf, Sabine Ruosch-Girsberger, Alessandra Bosch, Cosima Suter · 2026 · Hämostaseologie